ION363, ION363, Artificial Cerebrospinal Fluid (aCSF) for Injection, 5.0 mL (Placebo)
ION363-CS1
Phase 3 small_molecule active
Quick answer
ION363, ION363, Artificial Cerebrospinal Fluid (aCSF) for Injection, 5.0 mL (Placebo) for Amyotrophic Lateral Sclerosis with Fused in Sarcoma mutations is a Phase 3 program (small_molecule) at IONIS PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- IONIS PHARMACEUTICALS INC
- Indication
- Amyotrophic Lateral Sclerosis with Fused in Sarcoma mutations
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active